Tango Therapeutics IPO

Tango Therapeutics delivers the next generation of precision medicine to people with cancer that leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer.

Register for Details

For more details on financing and valuation for Tango Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Tango Therapeutics

Forge green plus iconForge green minus icon

What is Tango Therapeutics's IPO price?

Tango Therapeutics's IPO price is $10.95 as of 1/18/24.
Forge green plus iconForge green minus icon

What is Tango Therapeutics's funding to date?

Tango Therapeutics has raised $166.88MM to date.
Forge green plus iconForge green minus icon

When was Tango Therapeutics founded?

Tango Therapeutics was founded in 2014.

Tango Therapeutics Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
8/17/2020 Series B-1 $51.18MM raised $XXX.XX $XXX.XX
4/9/2020 Series B $60MM raised $XXX.XX $XXX.XX
3/30/2017 Series A $55.7MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 26, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.